PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.81%
Revenue growth below 50% of CRON.TO's 15.38%. Michael Burry would check for competitive disadvantage risks.
-7.28%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
23.28%
Gross profit growth below 50% of CRON.TO's 68.22%. Michael Burry would check for structural issues.
21.09%
Margin expansion below 50% of CRON.TO's 72.45%. Michael Burry would check for structural issues.
135.68%
R&D growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
0.96%
G&A growth less than half of CRON.TO's 45.66%. David Dodd would verify if efficiency advantage is structural.
7.45%
Marketing expense growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
-70.19%
Other expenses reduction while CRON.TO shows 115.04% growth. Joel Greenblatt would examine efficiency.
5.07%
Operating expenses growth above 1.5x CRON.TO's 1.10%. Michael Burry would check for inefficiency.
-3.48%
Both companies reducing total costs. Martin Whitman would check industry trends.
63.11%
Interest expense growth while CRON.TO reduces costs. John Neff would investigate differences.
13.90%
D&A growth above 1.5x CRON.TO's 6.98%. Michael Burry would check for excessive investment.
22.10%
EBITDA growth exceeding 1.5x CRON.TO's 10.86%. David Dodd would verify competitive advantages.
-43.85%
EBITDA margin decline while CRON.TO shows 22.74% growth. Joel Greenblatt would examine position.
119.76%
Operating income growth exceeding 1.5x CRON.TO's 29.45%. David Dodd would verify competitive advantages.
119.41%
Operating margin growth exceeding 1.5x CRON.TO's 38.85%. David Dodd would verify competitive advantages.
-65.63%
Other expenses reduction while CRON.TO shows 10.93% growth. Joel Greenblatt would examine advantage.
12.44%
Pre-tax income growth 50-75% of CRON.TO's 23.04%. Martin Whitman would scrutinize operations.
10.44%
Pre-tax margin growth exceeding 1.5x CRON.TO's 6.64%. David Dodd would verify competitive advantages.
495.97%
Tax expense growth while CRON.TO reduces burden. John Neff would investigate differences.
-0.34%
Net income decline while CRON.TO shows 30.89% growth. Joel Greenblatt would examine position.
-2.11%
Net margin decline while CRON.TO shows 13.44% growth. Joel Greenblatt would examine position.
5.93%
EPS growth below 50% of CRON.TO's 22.22%. Michael Burry would check for structural issues.
7.76%
Diluted EPS growth below 50% of CRON.TO's 25.00%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.